These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30867321)

  • 1. Preclinical development of an oral anti-
    Taylor MJ; von Geldern TW; Ford L; Hübner MP; Marsh K; Johnston KL; Sjoberg HT; Specht S; Pionnier N; Tyrer HE; Clare RH; Cook DAN; Murphy E; Steven A; Archer J; Bloemker D; Lenz F; Koschel M; Ehrens A; Metuge HM; Chunda VC; Ndongmo Chounna PW; Njouendou AJ; Fombad FF; Carr R; Morton HE; Aljayyoussi G; Hoerauf A; Wanji S; Kempf DJ; Turner JD; Ward SA
    Sci Transl Med; 2019 Mar; 11(483):. PubMed ID: 30867321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis.
    Aljayyoussi G; Tyrer HE; Ford L; Sjoberg H; Pionnier N; Waterhouse D; Davies J; Gamble J; Metuge H; Cook DAN; Steven A; Sharma R; Guimaraes AF; Clare RH; Cassidy A; Johnston KL; Myhill L; Hayward L; Wanji S; Turner JD; Taylor MJ; Ward SA
    Sci Rep; 2017 Mar; 7(1):210. PubMed ID: 28303006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-
    Wan Sulaiman WA; Kamtchum-Tatuene J; Mohamed MH; Ramachandran V; Ching SM; Sazlly Lim SM; Hashim HZ; Inche Mat LN; Hoo FK; Basri H
    Indian J Med Res; 2019 Jun; 149(6):706-714. PubMed ID: 31496523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AWZ1066S, a highly specific anti-
    Hong WD; Benayoud F; Nixon GL; Ford L; Johnston KL; Clare RH; Cassidy A; Cook DAN; Siu A; Shiotani M; Webborn PJH; Kavanagh S; Aljayyoussi G; Murphy E; Steven A; Archer J; Struever D; Frohberger SJ; Ehrens A; Hübner MP; Hoerauf A; Roberts AP; Hubbard ATM; Tate EW; Serwa RA; Leung SC; Qie L; Berry NG; Gusovsky F; Hemingway J; Turner JD; Taylor MJ; Ward SA; O'Neill PM
    Proc Natl Acad Sci U S A; 2019 Jan; 116(4):1414-1419. PubMed ID: 30617067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis.
    Halliday A; Guimaraes AF; Tyrer HE; Metuge HM; Patrick CN; Arnaud KO; Kwenti TD; Forsbrook G; Steven A; Cook D; Enyong P; Wanji S; Taylor MJ; Turner JD
    Parasit Vectors; 2014 Oct; 7():472. PubMed ID: 25338621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of ABBV-4083, a novel analog of Tylosin A that has potent anti-Wolbachia and anti-filarial activity.
    von Geldern TW; Morton HE; Clark RF; Brown BS; Johnston KL; Ford L; Specht S; Carr RA; Stolarik DF; Ma J; Rieser MJ; Struever D; Frohberger SJ; Koschel M; Ehrens A; Turner JD; Hübner MP; Hoerauf A; Taylor MJ; Ward SA; Marsh K; Kempf DJ
    PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007159. PubMed ID: 30818326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boron-Pleuromutilins as Anti- Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic Filariasis.
    Jacobs RT; Lunde CS; Freund YR; Hernandez V; Li X; Xia Y; Carter DS; Berry PW; Halladay J; Rock F; Stefanakis R; Easom E; Plattner JJ; Ford L; Johnston KL; Cook DAN; Clare R; Cassidy A; Myhill L; Tyrer H; Gamble J; Guimaraes AF; Steven A; Lenz F; Ehrens A; Frohberger SJ; Koschel M; Hoerauf A; Hübner MP; McNamara CW; Bakowski MA; Turner JD; Taylor MJ; Ward SA
    J Med Chem; 2019 Mar; 62(5):2521-2540. PubMed ID: 30730745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis.
    Sharma R; Al Jayoussi G; Tyrer HE; Gamble J; Hayward L; Guimaraes AF; Davies J; Waterhouse D; Cook DA; Myhill LJ; Clare RH; Cassidy A; Steven A; Johnston KL; Ford L; Turner JD; Ward SA; Taylor MJ
    Sci Rep; 2016 Mar; 6():23458. PubMed ID: 26996237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corallopyronin A for short-course anti-wolbachial, macrofilaricidal treatment of filarial infections.
    Schiefer A; Hübner MP; Krome A; Lämmer C; Ehrens A; Aden T; Koschel M; Neufeld H; Chaverra-Muñoz L; Jansen R; Kehraus S; König GM; Pogorevc D; Müller R; Stadler M; Hüttel S; Hesterkamp T; Wagner K; Pfarr K; Hoerauf A
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008930. PubMed ID: 33284808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Eagle effect in the Wolbachia-worm symbiosis.
    Bulman CA; Chappell L; Gunderson E; Vogel I; Beerntsen B; Slatko BE; Sullivan W; Sakanari JA
    Parasit Vectors; 2021 Feb; 14(1):118. PubMed ID: 33627171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a high-throughput anti-Wolbachia whole-cell screen: a route to macrofilaricidal drugs against onchocerciasis and lymphatic filariasis.
    Clare RH; Cook DA; Johnston KL; Ford L; Ward SA; Taylor MJ
    J Biomol Screen; 2015 Jan; 20(1):64-9. PubMed ID: 25278497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Wolbachia drugs for filariasis.
    Johnston KL; Hong WD; Turner JD; O'Neill PM; Ward SA; Taylor MJ
    Trends Parasitol; 2021 Dec; 37(12):1068-1081. PubMed ID: 34229954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo efficacy of the boron-pleuromutilin AN11251 against Wolbachia of the rodent filarial nematode Litomosoides sigmodontis.
    Ehrens A; Lunde CS; Jacobs RT; Struever D; Koschel M; Frohberger SJ; Lenz F; Fendler M; Turner JD; Ward SA; Taylor MJ; Freund YR; Stefanakis R; Easom E; Li X; Plattner JJ; Hoerauf A; Hübner MP
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007957. PubMed ID: 31986143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis.
    Taylor MJ; Hoerauf A; Townson S; Slatko BE; Ward SA
    Parasitology; 2014 Jan; 141(1):119-27. PubMed ID: 23866958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-course quinazoline drug treatments are effective in the Litomosoides sigmodontis and Brugia pahangi jird models.
    Hübner MP; Gunderson E; Vogel I; Bulman CA; Lim KC; Koschel M; Ehrens A; Frohberger SJ; Fendler M; Tricoche N; Voronin D; Steven A; Chi V; Bakowski MA; Woods AK; Petrassi HM; McNamara CW; Beerntsen B; Chappell L; Sullivan W; Taylor MJ; Turner JD; Hoerauf A; Lustigman S; Sakanari JA
    Int J Parasitol Drugs Drug Resist; 2020 Apr; 12():18-27. PubMed ID: 31869759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinations of the azaquinazoline anti-
    Hegde S; Marriott AE; Pionnier N; Steven A; Bulman C; Gunderson E; Vogel I; Koschel M; Ehrens A; Lustigman S; Voronin D; Tricoche N; Hoerauf A; Hübner MP; Sakanari J; Aljayyoussi G; Gusovsky F; Dagley J; Hong DW; O'Neill P; Ward SA; Taylor MJ; Turner JD
    Front Microbiol; 2024; 15():1346068. PubMed ID: 38362501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis.
    Bulman CA; Bidlow CM; Lustigman S; Cho-Ngwa F; Williams D; Rascón AA; Tricoche N; Samje M; Bell A; Suzuki B; Lim KC; Supakorndej N; Supakorndej P; Wolfe AR; Knudsen GM; Chen S; Wilson C; Ang KH; Arkin M; Gut J; Franklin C; Marcellino C; McKerrow JH; Debnath A; Sakanari JA
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003534. PubMed ID: 25700363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphatic filariasis and onchocerciasis.
    Taylor MJ; Hoerauf A; Bockarie M
    Lancet; 2010 Oct; 376(9747):1175-85. PubMed ID: 20739055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxfendazole mediates macrofilaricidal efficacy against the filarial nematode Litomosoides sigmodontis in vivo and inhibits Onchocerca spec. motility in vitro.
    Hübner MP; Martin C; Specht S; Koschel M; Dubben B; Frohberger SJ; Ehrens A; Fendler M; Struever D; Mitre E; Vallarino-Lhermitte N; Gokool S; Lustigman S; Schneider M; Townson S; Hoerauf A; Scandale I
    PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008427. PubMed ID: 32628671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinations of registered drugs reduce treatment times required to deplete Wolbachia in the Litomosoides sigmodontis mouse model.
    Specht S; Pfarr KM; Arriens S; Hübner MP; Klarmann-Schulz U; Koschel M; Sternberg S; Martin C; Ford L; Taylor MJ; Hoerauf A
    PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006116. PubMed ID: 29300732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.